• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by Arteris Inc.

    6/6/25 4:46:46 PM ET
    $AIP
    Semiconductors
    Technology
    Get the next $AIP alert in real time by email
    8-K
    false 0001667011 0001667011 2025-06-03 2025-06-03
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(d)

    OF THE SECURITIES EXCHANGE ACT OF 1934

    Date of Report (date of earliest event reported): June 3, 2025

     

     

    ARTERIS, INC.

    (Exact name of Registrant, as specified in its charter)

     

     

     

    Delaware   001-40960   27-0117058

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File Number)

     

    (I.R.S. Employer

    Identification Number)

     

    900 E. Hamilton Avenue Suite 300

    Campbell, CA 95008

    (Address of principal executive offices, including Zip code)

    Registrant’s telephone number, including area code: (408) 470-7300

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading

    Symbol(s)

     

    Name of each exchange

    on which registered

    Common Stock, $0.001 par value per share   AIP   The Nasdaq Stock Market

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☒

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     
     


    Item 5.07

    Submission of Matters to a Vote of Security Holders

    On June 3, 2025, Arteris, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on two proposals, each of which is described in more detail in the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on April 23, 2025. Only stockholders of record as of the close of business on April 10, 2025, the record date for the Annual Meeting, were entitled to vote at the Annual Meeting. As of the record date, 41,463,290 shares of the Company’s voting common stock were outstanding and entitled to vote at the Annual Meeting. The tabulation of the stockholder votes on each proposal brought before the Annual Meeting is as follows:

    Proposal 1. The election of two Class I directors to hold office until the 2028 annual meeting of stockholders or until their respective successor is elected:

     

    Nominee

       Votes For      Votes Withheld      Broker
    Non-Votes
     

    K. Charles Janac

         27,307,847        107,614        4,325,257  

    S. Atiq Raza

         24,112,098        3,303,363        4,325,257  

    Proposal 2. The ratification of the selection by the audit committee of the board of directors of the Company of Deloitte & Touche, LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2025:

     

    Votes For

     

    Votes Against

     

    Abstentions

    31,548,805   131,865   60,048

    As a routine proposal under applicable rules, no broker non-votes were recorded in connection with this proposal.


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Date: June 6, 2025

     

    By:  

    /s/ Nick B. Hawkins

    Name:   Nick B. Hawkins
    Title:   Chief Financial Officer
    Get the next $AIP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIP

    DatePrice TargetRatingAnalyst
    8/6/2025$12.00 → $15.00Buy
    TD Cowen
    9/1/2023$11.00 → $12.00Outperform
    TD Cowen
    3/4/2022$32.00 → $23.00Outperform
    Cowen
    11/22/2021$27.00Outperform
    Northland Capital
    11/22/2021$24.00Market Perform
    BMO Capital Markets
    11/22/2021$30.00Outperform
    Cowen
    11/22/2021$33.00Buy
    Jefferies
    11/22/2021$35.00Buy
    Rosenblatt
    More analyst ratings

    $AIP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen reiterated coverage on Arteris with a new price target

    TD Cowen reiterated coverage of Arteris with a rating of Buy and set a new price target of $15.00 from $12.00 previously

    8/6/25 7:10:46 AM ET
    $AIP
    Semiconductors
    Technology

    TD Cowen reiterated coverage on Arteris with a new price target

    TD Cowen reiterated coverage of Arteris with a rating of Outperform and set a new price target of $12.00 from $11.00 previously

    9/1/23 7:31:29 AM ET
    $AIP
    Semiconductors
    Technology

    Cowen reiterated coverage on Arteris with a new price target

    Cowen reiterated coverage of Arteris with a rating of Outperform and set a new price target of $23.00 from $32.00 previously

    3/4/22 7:21:31 AM ET
    $AIP
    Semiconductors
    Technology

    $AIP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    VP and General Counsel Alpern Paul L exercised 5,000 shares at a strike of $0.56 and sold $77,376 worth of shares (5,000 units at $15.48) (SEC Form 4)

    4 - Arteris, Inc. (0001667011) (Issuer)

    2/4/26 4:58:24 PM ET
    $AIP
    Semiconductors
    Technology

    President and CEO Janac K Charles sold $318,974 worth of shares (17,884 units at $17.84) (SEC Form 4)

    4 - Arteris, Inc. (0001667011) (Issuer)

    1/20/26 5:21:46 PM ET
    $AIP
    Semiconductors
    Technology

    Large owner Bayview Legacy, Llc sold $318,974 worth of shares (17,884 units at $17.84) (SEC Form 4)

    4 - Arteris, Inc. (0001667011) (Issuer)

    1/20/26 5:21:22 PM ET
    $AIP
    Semiconductors
    Technology

    $AIP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Arteris to Announce Financial Results for the Fourth Quarter and Year End 2025 on Thursday, February 12, 2026

    CAMPBELL, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading technology provider for accelerating semiconductor creation in the AI era, today announced it will release its financial results for the fourth quarter and full year ended December 31, 2025, after market close on Thursday, February 12, 2026. Management will host a conference call on Thursday, February 12, 2026, at 4:30 PM ET to discuss these results. The call will be available, live, to interested parties by dialing: United States/Canada Toll Free:+1-800-717-1738International Toll:+1-646-307-1865 Please join the call 5-10 minutes prior to the scheduled start time to avoid a delay in connecting. A liv

    2/2/26 4:05:00 PM ET
    $AIP
    Semiconductors
    Technology

    Arteris Announces New Employment Inducement Grants

    CAMPBELL, Calif., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading technology provider for accelerating semiconductor creation in the AI era, today announced that the compensation committee of the company's board of directors has granted an aggregate of 477,208 restricted stock units (RSUs) to 25 newly hired employees as inducement awards under the company's 2022 Employee Inducement Incentive Plan. The grants were made in accordance with Nasdaq Listing Rule 5635(c)(4). The effective RSU grant date was January 15, 2026 and it was approved by the company's board of directors. About Arteris Arteris is a leading provider of semiconductor technology that accelerates t

    1/16/26 4:05:00 PM ET
    $AIP
    Semiconductors
    Technology

    Arteris Closes Acquisition of Cycuity

    CAMPBELL, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading technology provider for accelerating semiconductor creation in the AI era, today announced it has closed its previously announced acquisition of Cycuity, Inc., a leading provider and domain expert of semiconductor cybersecurity assurance technology. Semiconductor cybersecurity assurance is becoming critical to all types of chip designs, as the threat landscape has expanded to the hardware layer. Silicon vulnerabilities can result in compromised systems exposing unprotected information, a trend accelerated by the proliferation of AI and chiplets. Reported new Common Vulnerabilities and Exposures (CVEs

    1/14/26 4:05:00 PM ET
    $AIP
    Semiconductors
    Technology

    $AIP
    SEC Filings

    View All

    SEC Form 144 filed by Arteris Inc.

    144 - Arteris, Inc. (0001667011) (Subject)

    1/7/26 4:26:46 PM ET
    $AIP
    Semiconductors
    Technology

    SEC Form 144 filed by Arteris Inc.

    144 - Arteris, Inc. (0001667011) (Subject)

    1/6/26 4:26:21 PM ET
    $AIP
    Semiconductors
    Technology

    SEC Form 144 filed by Arteris Inc.

    144 - Arteris, Inc. (0001667011) (Subject)

    1/2/26 4:32:32 PM ET
    $AIP
    Semiconductors
    Technology

    $AIP
    Leadership Updates

    Live Leadership Updates

    View All

    Joachim Kunkel Joins Arteris Board of Directors

    CAMPBELL, Calif., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of system IP which accelerates system-on-chip (SoC) creation, today announced that Joachim Kunkel will join its Board of Directors. Mr. Kunkel most recently served as the General Manager of the Intellectual Property (IP) business unit at Synopsys where he grew Synopsys' IP revenue to over $1.5 billion, making Synopsys the second largest semiconductor IP company in the world. With three decades of experience at Synopsys, Mr. Kunkel brings a wealth of knowledge and leadership to Arteris. Prior to joining Synopsys, Joachim Kunkel co-founded and served as managing director of CADIS GmbH, where

    9/16/24 5:00:00 PM ET
    $AIP
    Semiconductors
    Technology

    $AIP
    Financials

    Live finance-specific insights

    View All

    Arteris to Announce Financial Results for the Fourth Quarter and Year End 2025 on Thursday, February 12, 2026

    CAMPBELL, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading technology provider for accelerating semiconductor creation in the AI era, today announced it will release its financial results for the fourth quarter and full year ended December 31, 2025, after market close on Thursday, February 12, 2026. Management will host a conference call on Thursday, February 12, 2026, at 4:30 PM ET to discuss these results. The call will be available, live, to interested parties by dialing: United States/Canada Toll Free:+1-800-717-1738International Toll:+1-646-307-1865 Please join the call 5-10 minutes prior to the scheduled start time to avoid a delay in connecting. A liv

    2/2/26 4:05:00 PM ET
    $AIP
    Semiconductors
    Technology

    Arteris Announces Financial Results for the Third Quarter and Estimated Fourth Quarter and Updated Full Year 2025 Guidance

    CAMPBELL, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of semiconductor system IP for accelerating system-on-chip (SoC) creation, today announced financial results for the third quarter ended September 30, 2025 and provided estimated fourth quarter and updated full year 2025 guidance. "In the third quarter of 2025, we achieved another record with Annual Contract Value plus royalties of $74.9 million, up 24% year-over-year. In addition, we exited the quarter with $104.7 million in Remaining Performance Obligations, up 34% year-over-year and exceeding $100.0 million for the first time in our history," said K. Charles Janac, President and CEO of Ar

    11/4/25 4:06:00 PM ET
    $AIP
    Semiconductors
    Technology

    Arteris to Announce Financial Results for the Third Quarter 2025 on Tuesday, November 4, 2025

    CAMPBELL, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of system IP for accelerating semiconductor creation, today announced it will release its financial results for the third quarter ended September 30, 2025, after market close on Tuesday, November 4, 2025. Management will host a conference call on Tuesday, November 4, 2025, at 4:30 PM ET to discuss these results. The call will be available, live, to interested parties by dialing: United States/Canada Toll Free:+1-800-717-1738International Toll:+1-646-307-1865     Please join the call 5-10 minutes prior to the scheduled start time to avoid a delay in connecting. A live webcast will be availabl

    10/23/25 4:05:00 PM ET
    $AIP
    Semiconductors
    Technology

    $AIP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Arteris Inc.

    SC 13G/A - Arteris, Inc. (0001667011) (Subject)

    11/13/24 4:32:26 PM ET
    $AIP
    Semiconductors
    Technology

    SEC Form SC 13G filed by Arteris Inc.

    SC 13G - Arteris, Inc. (0001667011) (Subject)

    6/27/24 3:46:24 PM ET
    $AIP
    Semiconductors
    Technology

    SEC Form SC 13G/A filed by Arteris Inc. (Amendment)

    SC 13G/A - Arteris, Inc. (0001667011) (Subject)

    1/24/24 4:05:55 PM ET
    $AIP
    Semiconductors
    Technology